Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis
- PMID: 29550111
- PMCID: PMC6067995
- DOI: 10.1016/j.semarthrit.2018.01.010
Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis
Abstract
Objectives: Phenotypes differ between late- and early-onset systemic lupus erythematosus (SLE). Prior studies suggested that there may be more pulmonary disease among late-onset patients. Our objective was to perform a systematic review and meta-analysis to evaluate the differences in pulmonary manifestations in late- versus early-onset SLE.
Methods: We searched the literature using PubMed, CINAHL, Web of Science, Cochrane Library, and EMBASE. We excluded studies that did not include American College of Rheumatology SLE classification criteria, an early-onset SLE comparison group, or those that defined late-onset SLE as <50 years of age. We rated study quality using the Newcastle-Ottawa Quality Scale. We used Forest plots to compare odds ratios (95% confidence intervals) of pulmonary manifestations by age. Study heterogeneity was assessed using I2.
Results: Thirty-nine studies, representing 10,963 early-onset and 1656 late-onset patients with SLE, met eligibility criteria. The odds of developing several pulmonary manifestations were higher in the late-onset group. Interstitial lung disease (ILD) was nearly three times more common (OR = 2.56 (1.27, 5.16)). Pleuritis (OR = 1.53 (1.19, 1.96)) and serositis (OR = 1.31 (1.05, 1.65)) were also more common in the late-onset group. The mean Newcastle-Ottawa Quality Scale score for study quality was moderate (6.3 ± 0.7, scale 0-9).
Conclusions: Pulmonary manifestations of SLE were more common in late-onset SLE patients compared to their younger peers, in particular ILD and serositis. Age-related changes of the immune system, tobacco exposure, race, and possible overlap with Sjögren's syndrome should be examined in future studies.
Keywords: Interstitial lung disease (ILD); Pleuritis; Pulmonary manifestations; Serositis; Systemic lupus erythematosus (SLE).
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
All other authors have no direct financial, consultant, or institutional conflict of interest pertaining to this manuscript.
Figures




Similar articles
-
Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus.Lupus. 2016 May;25(6):652-7. doi: 10.1177/0961203315625460. Epub 2016 Jan 12. Lupus. 2016. PMID: 26762471
-
Serositis related to systemic lupus erythematosus: prevalence and outcome.Lupus. 2005;14(10):822-6. doi: 10.1191/0961203305lu2187oa. Lupus. 2005. PMID: 16302677
-
Neuropsychiatric lupus in late- and early-onset systemic lupus erythematosus patients: a systematic review and meta-analysis.Rheumatology (Oxford). 2024 Jan 4;63(1):8-15. doi: 10.1093/rheumatology/kead297. Rheumatology (Oxford). 2024. PMID: 37341643 Free PMC article.
-
Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review.Lupus. 2012 Sep;21(10):1135-48. doi: 10.1177/0961203312450087. Epub 2012 May 31. Lupus. 2012. PMID: 22652632 Review.
-
Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?Lupus. 2015 Jul;24(8):788-95. doi: 10.1177/0961203314563134. Epub 2014 Dec 11. Lupus. 2015. PMID: 25504653
Cited by
-
A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus.Clin Rev Allergy Immunol. 2022 Dec;63(3):311-329. doi: 10.1007/s12016-021-08917-7. Epub 2022 Jan 22. Clin Rev Allergy Immunol. 2022. PMID: 35064901 Review.
-
The interplay between rheumatic diseases and pulmonary health.Rheumatol Int. 2024 Jul;44(7):1179-1184. doi: 10.1007/s00296-024-05565-w. Epub 2024 Mar 20. Rheumatol Int. 2024. PMID: 38509351 Review.
-
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry.Rheumatology (Oxford). 2020 Aug 1;59(8):2043-2051. doi: 10.1093/rheumatology/kez562. Rheumatology (Oxford). 2020. PMID: 31808534 Free PMC article.
-
A Rare Combination of Gastric Mucosa-associated Lymphoid Tissue Lymphoma, Autoimmune Gastritis, Thyroiditis, Hemolysis, and Systemic Lupus Erythematosus.Intern Med. 2020;59(1):61-65. doi: 10.2169/internalmedicine.3191-19. Epub 2020 Jan 1. Intern Med. 2020. PMID: 31902909 Free PMC article.
-
Pulmonary Involvement in Systemic Lupus Erythematosus: A Potentially Overlooked Condition.Biomedicines. 2025 Jun 16;13(6):1485. doi: 10.3390/biomedicines13061485. Biomedicines. 2025. PMID: 40564204 Free PMC article. Review.
References
-
- Ward MM, Polisson RP. A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum. 1989;32(10):1226–32. - PubMed
-
- Mak SK, Lam EK, Wong AK. Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus. 1998;7(1):23–28. - PubMed
-
- Bertoli AM, et al. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus. 2007;16(6):410–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous